{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:51:32Z","timestamp":1786546292501,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACG Case Rep J","ACG Case Reports Journal"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Tumor necrosis factor-\u03b1 inhibitor (TNF-\u03b1) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-\u03b1, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-\u03b1 therapy.<\/jats:p>","DOI":"10.14309\/crj.0000000000000075","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T09:26:19Z","timestamp":1561713979000},"page":"e00075","source":"Crossref","is-referenced-by-count":1,"title":["Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease"],"prefix":"10.14309","volume":"6","author":[{"given":"I.K.","family":"Liyanage","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Niriella","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Univeristy of Kelaniya, Ragama, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"de Silva","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Univeristy of Kelaniya, Ragama, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"de Silva","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Univeristy of Kelaniya, Ragama, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"de Silva","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Univeristy of Kelaniya, Ragama, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"3","key":"R1-20231027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"R2-20231027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: Management of Crohn's disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"R3-20231027","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MOG.0000000000000191","article-title":"Complications of biologics in inflammatory bowel disease","volume":"31","author":"Sousa","year":"2015","journal-title":"Curr Opin Gastroenterol."},{"issue":"5","key":"R4-20231027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/2050640615590302","article-title":"Biologics in inflammatory bowel disease: What are the data?","volume":"3","author":"C\u00f4t\u00e9-Daigneault","year":"2015","journal-title":"United Eur Gastroenterol J."},{"issue":"3","key":"R5-20231027","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ibd\/izx072","article-title":"Infliximab for Crohn's disease: More than 13 years of real-world experience","volume":"24","author":"Lichtenstein","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"R6-20231027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3347\/kjp.2008.46.3.119","article-title":"Clinical and pathological aspects of filarial lymphedema and its management","volume":"46","author":"Shenoy","year":"2008","journal-title":"Korean J Parasitol."},{"issue":"1","key":"R8-20231027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2883-6-2","article-title":"Morbidity management in the global programme to eliminate lymphatic filariasis: A review of the scientific literature","volume":"6","author":"Addiss","year":"2007","journal-title":"Filaria J."},{"issue":"11","key":"R9-20231027","doi-asserted-by":"crossref","first-page":"e3281","DOI":"10.1371\/journal.pntd.0003281","article-title":"A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration","volume":"8","author":"Rao","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"issue":"3","key":"R11-20231027","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side\u2010effects in patients with rheumatic diseases during application of tumour necrosis factor\u2010\u03b1 antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol."},{"issue":"12","key":"R12-20231027","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ecco-jcc\/jjw109","article-title":"Asymptomatic parasitic infection in a Crohn's disease patient on anti-TNF\u03b1 therapy: An alert for our patients?","volume":"10","author":"Cocca","year":"2016","journal-title":"J Crohn's Colitis."},{"key":"R13-20231027","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.12659\/AJCR.906391","article-title":"Disseminated nocardiosis associated with treatment with infliximab in a patient with ulcerative colitis","volume":"18","author":"Garner","year":"2017","journal-title":"Am J Case Rep."},{"issue":"2","key":"R14-20231027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3748\/wjg.14.165","article-title":"Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature","volume":"14","author":"Koloski","year":"2008","journal-title":"World J Gastroenterol."}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201906000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:54:45Z","timestamp":1786542885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201906000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.0000000000000075","relation":{},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}